JCR Pharmaceuticals Co., Ltd. provided earnings guidance for the full year of 2023. For the full year, the company expects sales of JPY 54 billion and the operating income of JPY14,500 million; and ordinary profit of JPY 14,500 million; and net profit of JPY 10,300 million.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
536 JPY | -2.37% | -8.53% | -54.27% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-54.27% | 437M | |
+38.59% | 727B | |
-7.89% | 347B | |
+15.66% | 319B | |
+0.24% | 274B | |
+13.19% | 238B | |
+7.01% | 204B | |
-6.50% | 203B | |
+4.23% | 161B | |
-1.70% | 160B |
- Stock Market
- Equities
- 4552 Stock
- News JCR Pharmaceuticals Co., Ltd.
- JCR Pharmaceuticals Co., Ltd. Provides Earnings Guidance for the Full Year of 2023